Open Philanthropy recommended an investment of $487,356 in VenomAid, a Danish company commercializing inexpensive rapid diagnostics for many different species of venomous snakes.
If clinics can rapidly identify which snake species caused a given snakebite, they can quickly administer the correct antivenom, which we believe will substantially lower snakebite morbidity and mortality.
This falls within our focus area of scientific research, specifically within our interest in advancing human health and wellbeing.